Vifor Inc.   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Berne Switzerland (1927)
Status: Acquired by CSL Behring (2021)

Organization Overview

First Clinical Trial
2003
NCT03047954
First Marketed Drug
1950
iron sucrose (venofer)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Galenica | Galenica SA | VIFORFRANCE | Vifor Inc. | Vifor (International) Inc. | Vifor Pharma | VIFOR PHARMA | Vifor Pharma, CH-8152 Glattbrugg, Switzerland | Vifor Pharma Group | Vifor Pharma Management Ltd.